Literature DB >> 29115524

High expression of long non‑coding HOTAIR correlated with hepatocarcinogenesis and metastasis.

Da-Ni Zhong1, Yi-Huan Luo2, Wei-Jia Mo3, Xin Zhang2, Zhong Tan2, Na Zhao2, Si-Min Pang2, Gang Chen3, Min-Hua Rong2, Wei Tang4.   

Abstract

HOX transcript antisense RNA (HOTAIR), a newly discovered long noncoding RNA (lncRNA), has been reported to be a poor prognostic marker in many types of cancers. The current study attempted to investigate the biological roles and clinicopathlogical implications of HOTAIR in hepatocellular carcinoma (HCC), as well as understand the molecular mechanisms of HOTAIR in HCC progression. HOTAIR expression in 95 HCC patients with paired HCC tissues and adjacent non‑cancer tissues were investigated using quantitative reverse transcription‑polymerase chain reaction. The association between HOTAIR expression and clinicopathological features was assessed. The effects of HOTAIR were examined in vitro assays by silencing the lncRNA. Pathway analyses were performed to illustrate the biological functions of the HOTAIR and coexpression genes. The expression level of HOTAIR was observed significantly higher in the HCC tissue than the adjacent non‑tumor tissue. HOTAIR expression levels were significantly higher in tumor samples from patients with distant metastasis, advanced stage, portal vein tumor embolus, vasoinvasion, tumor capsular infiltration or positive nm23 expression than those from patients without these conditions, correspondingly. The silencing of HOTAIR in liver cancer cells induced the inhibition of cell proliferation and promotion of apoptosis. Several pathways such as extracellular matrix‑receptor interaction, focal adhesion, pathways in cancer were annotated with the HOTAIR and coexpression genes. In summary, the present analysis indicates that HOTAIR might be an oncogene in HCC. It functions though promoting tumor cell growth and inhibiting apoptosis. HOTAIR may potentially be involved in HCC metastatic progression by several pathways correlated to cell adhesion, and may be a therapeutic target in future.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29115524     DOI: 10.3892/mmr.2017.7999

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  12 in total

1.  Advancing Pan-cancer Gene Expression Survial Analysis by Inclusion of Non-coding RNA.

Authors:  Bo Ye; Jianxin Shi; Huining Kang; Olufunmilola Oyebamiji; Deirdre Hill; Hui Yu; Scott Ness; Fei Ye; Jie Ping; Jiapeng He; Jeremy Edwards; Ying-Yong Zhao; Yan Guo
Journal:  RNA Biol       Date:  2019-10-18       Impact factor: 4.652

2.  Overexpressed BSG related to the progression of lung adenocarcinoma with high-throughput data-mining, immunohistochemistry, in vitro validation and in silico investigation.

Authors:  Wen-Ting Huang; Xia Yang; Rong-Quan He; Jie Ma; Xiao-Hua Hu; Wei-Jia Mo; Gang Chen
Journal:  Am J Transl Res       Date:  2019-08-15       Impact factor: 4.060

Review 3.  Current Research on Non-Coding Ribonucleic Acid (RNA).

Authors:  Jing Wang; David C Samuels; Shilin Zhao; Yu Xiang; Ying-Yong Zhao; Yan Guo
Journal:  Genes (Basel)       Date:  2017-12-05       Impact factor: 4.096

Review 4.  The Role of Long Non-Coding RNAs in Hepatocarcinogenesis.

Authors:  Manuela Lanzafame; Gaia Bianco; Luigi M Terracciano; Charlotte K Y Ng; Salvatore Piscuoglio
Journal:  Int J Mol Sci       Date:  2018-02-28       Impact factor: 5.923

5.  A Systematic Review of Long Noncoding RNAs in Hepatocellular Carcinoma: Molecular Mechanism and Clinical Implications.

Authors:  Xiaoge Hu; Jiahong Jiang; Qiuran Xu; Chao Ni; Liu Yang; Dongsheng Huang
Journal:  Biomed Res Int       Date:  2018-07-09       Impact factor: 3.411

6.  miR‑146a‑5p targets TCSF and influences cell growth and apoptosis to repress NSCLC progression.

Authors:  Wen-Ting Huang; Rong-Quan He; Xiao-Jiao Li; Jie Ma; Zhi-Gang Peng; Jin-Cai Zhong; Xiao-Hua Hu; Gang Chen
Journal:  Oncol Rep       Date:  2019-02-25       Impact factor: 3.906

Review 7.  Progress of HOTAIR-microRNA in hepatocellular carcinoma.

Authors:  Bing-Rong Wang; Dong-Xia Chu; Mei-Yu Cheng; Yu Jin; Hao-Ge Luo; Na Li
Journal:  Hered Cancer Clin Pract       Date:  2022-01-29       Impact factor: 2.857

8.  Targeting Long Non-Coding RNAs in Hepatocellular Carcinoma: Progress and Prospects.

Authors:  Xinrong Lin; Xiaosong Xiang; Bing Feng; Hao Zhou; Ting Wang; Xiaoyuan Chu; Rui Wang
Journal:  Front Oncol       Date:  2021-06-25       Impact factor: 6.244

Review 9.  Molecular mechanisms of circular RNAs, transforming growth factor-β, and long noncoding RNAs in hepatocellular carcinoma.

Authors:  Wenkang Shang; Gabriel Komla Adzika; Yujie Li; Qike Huang; Ningding Ding; Bianca Chinembiri; Mohammad Sajjad Ibn Rashid; Jeremiah Ong'achwa Machuki
Journal:  Cancer Med       Date:  2019-09-15       Impact factor: 4.452

10.  Ginsenoside-Rg3 inhibits the proliferation and invasion of hepatoma carcinoma cells via regulating long non-coding RNA HOX antisense intergenic.

Authors:  Zhongjian Pu; Fei Ge; Yajun Wang; Ziyu Jiang; Shilin Zhu; Shukui Qin; Qijun Dai; Hua Liu; Haiqing Hua
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.